Among them, VEGF-VEGFR2 (also known as the kinase insert domain-containing receptor, KDR, or fetal liver kinase-1, Flk-1) [20] binding in cancer cells stimulates the secretion of MMPs, leading to ECM degradation and providing a pathway for cells to invade nearby tissues. This evidence concerns the gene KDR and cancer.